Real-World watch: tracking side effects of lung disease drug
NCT ID NCT04325217
Summary
This study is monitoring the long-term safety of Ofev capsules in Japanese patients with lung disease caused by systemic scleroderma. Researchers are tracking side effects, particularly stomach and intestinal issues like diarrhea and nausea, in real-world use. The goal is to confirm the safety profile seen in earlier clinical trials.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG DISEASES, INTERSTITIAL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nippon Boehringer Ingelheim Co., Ltd.
Tokyo, 1416017, Japan
Conditions
Explore the condition pages connected to this study.